Cyprumed Oral Delivery Technology Enters Clinical Stage With MSD
INNSBRUCK, Austria — September 29, 2026 Cyprumed GmbH announced that MSD has initiated a Phase 1 clinical trial of...
pharmaceutical technology
Advertisement
Aptar Pharma, Aceso Advance Inhaled ASO Therapy
Crystal Lake, Illinois — September 7, 2026 Aptar Pharma announced a collaboration with Aceso Therapeutics to advance development activities...
Novo Nordisk and AWS Partner to Accelerate AI Drug Discovery
Bagsværd, Denmark, August 10, 2026 Novo Nordisk and Amazon Web Services (AWS) announced a strategic partnership aimed at accelerating...
Simulations Plus to Join Altaris in $375M Acquisition Deal
RESEARCH TRIANGLE PARK, N.C., June 16, 2026 Simulations Plus, a global leader in model-informed and AI-accelerated drug development software,...
Enhanced Group Secures $50 Million Financing to Accelerate Health Platform Growth
NEW YORK, June 15, 2026 Enhanced Group Inc. has announced a $50 million strategic equity financing through a private...
Advertisements
Harbour BioMed and BioMap Unveil AI-Powered MegaStream TechBio Platform
CAMBRIDGE, Mass., ROTTERDAM, Netherlands, and SHANGHAI, China, June 15, 2026 Harbour BioMed and BioMap have announced a long-term strategic...
Innocan Pharma Reports Strong Q1 Growth and Pipeline Progress
HERZLIYA, Israel and CALGARY, Alberta, May 27, 2026 Innocan Pharma Corporation has reported strong first-quarter 2026 financial results, highlighting...
Persistent Strengthens Life Sciences AI Through Databricks
SANTA CLARA, Calif. and PUNE, India , May 7, 2026 Persistent Systems announced it has achieved the Databricks Brickbuilder...
AI Grant Aims to Boost Biologics Developability at Just – Evotec
SAN DIEGO | January 8, 2026 — Just – Evotec Biologics, a collaboration between Evotec SE and Just –...
Advertisement
